Skip to content

Silvaco Group, Inc. SVCO Tax deficiencies on share-based payments

Tax deficiencies on share-based payments at other companies

V2X logo
V2XVVX
0.8%-5.4pp
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
2%+1.3pp
Haverty Furniture Companies logo
Haverty Furniture CompaniesHVT
2.1%+1.7pp
TRV
Trevi Therapeutics, Inc.TRVI
-2.8%+3.5pp
ATN International logo
ATN InternationalATNI
-2.8%
Calix logo
CalixCALX
-24.3%-33.1pp

Other financials

Income statement

See full
Revenue$17.8M+26.0%
Gross profit$15.3M+38.5%
Operating income-$5.7M+71.2%
Net income-$5.9M+69.6%
EPS (diluted)-$0.19+71.6%

Balance sheet

See full
Cash & equivalents$10.9M-63.0%
Total debt$2.0M+32.3%
Total equity$76.7M-8.2%
Total assets$111.5M-19.3%

Cash flow

See full
Operating cash flow-$11.0M-871%
CapEx--100%
Free cash flow-$11.0M-795%

Valuation

See full
Market cap$399.62M+200%
Enterprise value$390.7M+271%
P/S+3.7×

Profitability

See full
Gross margin80.4%+3.0pp
Operating margin-47.8%-17.4pp
Net margin-41.7%
FCF margin-66.4%-2,213pp

Returns & leverage

See full
Return on equity-34.7%
Debt / equity0.0×
Current ratio1.4×-0.7×

Where this comes from

Reported directly by Silvaco Group, Inc. in its filing.

Tagged under the XBRL concept svco:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedPaymentArrangementDeficiencyPercent.

The official record: Silvaco Group, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Silvaco Group, Inc.'s tax deficiencies on share-based payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Silvaco Group, Inc.'s tax deficiencies on share-based payments?
Silvaco Group, Inc. (SVCO) reported tax deficiencies on share-based payments of -1% in Q4 2025.
What does tax deficiencies on share-based payments mean?
Measures the negative impact on the effective tax rate due to the non-deductibility of certain share-based payment expenses under local tax codes. Monitoring this helps investors understand the tax efficiency of the company's equity incentive programs.